🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

abSorbable vErsus Non-absorbable SuturEs for Wound Closure in Carpal Tunnel Release

RecruitingNAAges 18 Years - anyAllGelre Hospitals
NCT05431101 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Carpal Tunnel Syndrome is a prevalent condition, up to 9% in women and 0.6% in men. Surgical decompression in the most effective treatment. After surgery, approximately 1,8% of the patients develop a wound infection. Possibly, the type of sutures used can influence the prevalence of wound infection. In this RCT the incidence of infection is investigated between the use of absorbable versus non-absorbable sutures in carpal tunnel release.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: • indication for carpal tunnel release Exclusion Criteria: * carpal tunnel syndrome which has yet been operated * injection with corticosteroids
💊

What it tests

  • Carpal Tunnel Release
📍

Where

2 sites
Gelre Ziekenhuizen
Apeldoorn, Netherlands
Deventer Ziekenhuis
Deventer, Netherlands
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy